205 related articles for article (PubMed ID: 18642159)
1. Clinical evaluation for diagnosing active TB disease and transitional change of two commercial blood tests.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Okimoto N; Matsushima T; Kageoka T; Oka M
Scand J Infect Dis; 2008; 40(8):629-34. PubMed ID: 18642159
[TBL] [Abstract][Full Text] [Related]
2. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
Harada N
Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of a T cell-based assay in the diagnosis of extrapulmonary tuberculosis.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
Respirology; 2009 Mar; 14(2):276-81. PubMed ID: 19210655
[TBL] [Abstract][Full Text] [Related]
5. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis.
Kobashi Y; Obase Y; Fukuda M; Yoshida K; Miyashita N; Oka M
Clin Infect Dis; 2006 Dec; 43(12):1540-6. PubMed ID: 17109285
[TBL] [Abstract][Full Text] [Related]
6. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
J Infect; 2009 Mar; 58(3):197-204. PubMed ID: 18848730
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 2 interferon-gamma assays and Roche Cobas Amplicor Mycobacterium tuberculosis assay for rapid diagnosis of tuberculosis among patients with suspected tuberculosis in Taiwan.
Chou CH; Hsu HL; Lee LN; Hsueh PR; Luh KT
J Microbiol Immunol Infect; 2009 Jun; 42(3):251-7. PubMed ID: 19812859
[TBL] [Abstract][Full Text] [Related]
8. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M. tuberculosis infection.
Soysal A; Torun T; Efe S; Gencer H; Tahaoglu K; Bakir M
Int J Tuberc Lung Dis; 2008 Jan; 12(1):50-6. PubMed ID: 18173877
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
[TBL] [Abstract][Full Text] [Related]
11. [Application and problems of quantiFERON TB-2G for tuberculosis control programs--(2) clinical use of quantiFERON TB-2G].
Kawabe Y
Kekkaku; 2007 Jan; 82(1):61-6. PubMed ID: 17310783
[TBL] [Abstract][Full Text] [Related]
12. Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test.
Soborg B; Andersen AB; Larsen HK; Weldingh K; Andersen P; Kofoed K; Ravn P
Scand J Infect Dis; 2007; 39(6-7):554-9. PubMed ID: 17577817
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an in vitro assay for interferon gamma production in response to the Mycobacterium tuberculosis-synthesized peptide antigens ESAT-6 and CFP-10 and the PPD skin test.
Taggart EW; Hill HR; Ruegner RG; Litwin CM
Am J Clin Pathol; 2006 Mar; 125(3):467-73. PubMed ID: 16613353
[TBL] [Abstract][Full Text] [Related]
14. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
Soborg B; Ruhwald M; Hetland ML; Jacobsen S; Andersen AB; Milman N; Thomsen VO; Jensen DV; Koch A; Wohlfahrt J; Ravn P
J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis infection in drug users: interferon-gamma release assay performance.
Grimes CZ; Hwang LY; Williams ML; Austin CM; Graviss EA
Int J Tuberc Lung Dis; 2007 Nov; 11(11):1183-9. PubMed ID: 17958979
[TBL] [Abstract][Full Text] [Related]
16. T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment.
Domínguez J; De Souza-Galvão M; Ruiz-Manzano J; Latorre I; Prat C; Lacoma A; Milà C; Jiménez MA; Blanco S; Maldonado J; Altet N; Ausina V
Diagn Microbiol Infect Dis; 2009 Jan; 63(1):43-51. PubMed ID: 19026511
[TBL] [Abstract][Full Text] [Related]
17. [Effects of prophylaxis on QuantiFERON TB-2G responses among children].
Higuchi K; Okada K; Harada N; Mori T
Kekkaku; 2008 Sep; 83(9):603-9. PubMed ID: 18979994
[TBL] [Abstract][Full Text] [Related]
18. Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection.
Petrucci R; Abu Amer N; Gurgel RQ; Sherchand JB; Doria L; Lama C; Ravn P; Ruhwald M; Yassin M; Harper G; Cuevas LE
Pediatr Infect Dis J; 2008 Dec; 27(12):1073-7. PubMed ID: 18946366
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tuberculin skin test with a whole-blood interferon gamma assay and ELISA, in HIV positive children and adolescents with TB.
Stavri H; Ene L; Popa GL; Duiculescu D; Murgoci G; Marica C; Ulea I; Cus G; Popa MI
Roum Arch Microbiol Immunol; 2009; 68(1):14-9. PubMed ID: 19507622
[TBL] [Abstract][Full Text] [Related]
20. Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.
Behar SM; Shin DS; Maier A; Coblyn J; Helfgott S; Weinblatt ME
J Rheumatol; 2009 Mar; 36(3):546-51. PubMed ID: 19228655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
